Understand the source comparison
TB-4 Research Variables to Control: Storage and Handling Comparison
Storage Temperature (Lyophilized) −20°C or colder, <40% RH >5°C variance causes 8–15% potency loss per month Data-logging thermometer, ±0.5°C accuracy, calibrated quarterly Non-negotiable. Temperature excursions are the #1 cause of unexplained experimental var
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Storage Temperature (Lyophilized)
- −20°C or colder, <40% RH
- >5°C variance causes 8–15% potency loss per month
- Data-logging thermometer, ±0.5°C accuracy, calibrated quarterly
- Non-negotiable. Temperature excursions are the #1 cause of unexplained experimental variance in peptide studies.
- Reconstitution Buffer Temp
- 2–8°C during mixing
- Room-temp reconstitution = 10–15% activity loss in first 24h
- Pre-chill buffer, verify with contact thermometer before use
- Often overlooked. Labs assume cold storage compensates. It doesn't reverse denaturation that occurred during mixing.
- Post-Reconstitution Storage
- 2–8°C, use within 28 days (bacteriostatic water)
- Potency drops 2–3% per week beyond 28 days; bacterial contamination risk increases
- Date vials at reconstitution; discard after 28 days regardless of appearance
- Treat 28-day limit as absolute. 'Looks clear' is not a potency assay. Degraded peptide can appear visually identical to fresh solution.
- Light Exposure
- Amber vials or foil-wrapped; <5 minutes cumulative ambient light
- Photooxidation of methionine residues; 5–10% activity loss per hour under laboratory fluorescent lighting
- Store in light-blocking secondary container; handle under reduced lighting
- Severely underestimated. Most labs store peptides on open shelves under continuous fluorescent lighting. Easily fixable with amber vials.
- Injection Site Rotation
- Minimum 4-zone rotation; no re-injection within 3cm until all zones used
- 30–40% bioavailability reduction by week 6 at repeated sites due to fibrotic tissue formation
- Maintain injection site log with body diagram; photograph sites if needed
- The variable protocols ignore entirely. Site rotation is not optional. It's a fundamental pharmacokinetic control.